CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 113 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $119,574 | +28.7% | 9,460 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $92,897 | -1.3% | 9,460 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $94,127 | +12.6% | 9,460 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $83,626 | +88.3% | 9,460 | +25.2% | 0.00% | +100.0% |
| Q3 2019 | $44,412 | -51.0% | 7,553 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $90,636 | -0.6% | 7,553 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $91,165 | -3.8% | 7,553 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $94,790 | +0.6% | 7,553 | +19.0% | 0.00% | 0.0% |
| Q3 2018 | $94,204 | -99.9% | 6,348 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $106,836,000 | -26.5% | 6,348 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $145,369,000 | +88539.6% | 6,348 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $164,000 | -9.4% | 6,348 | -51.1% | 0.00% | +100.0% |
| Q2 2017 | $181,000 | +36.1% | 12,976 | +9.7% | 0.00% | 0.0% |
| Q2 2016 | $133,000 | -17.9% | 11,833 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $162,000 | -27.7% | 11,833 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $224,000 | +0.9% | 11,833 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $222,000 | +26.1% | 11,833 | 0.0% | 0.00% | +100.0% |
| Q2 2015 | $176,000 | – | 11,833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |